| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-06 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-06 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |